MATURE B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for MATURE B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MATURE B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for MATURE B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost survival in kids with aggressive blood cancer
Disease control OngoingThis study tests whether adding the targeted drug rituximab to standard chemotherapy can improve outcomes for children and teens with aggressive B-cell lymphoma or leukemia. About 650 participants from Europe will receive different treatment schedules to find the best balance of …
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: University Hospital Muenster • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New combo therapy aims to boost survival in kids with aggressive lymphoma
Disease control OngoingThis study tests whether adding four doses of rituximab to an intensified chemotherapy regimen improves outcomes for children and teens with advanced B-cell non-Hodgkin lymphoma or B-cell acute leukemia. About 200 participants in China will receive the new treatment, and research…
Matched conditions: MATURE B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC